Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
28
0
1

Year Published

2011
2011
2017
2017

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 41 publications
(30 citation statements)
references
References 66 publications
1
28
0
1
Order By: Relevance
“…The number of immunocompromised patients has increased dramatically over recent decades [2]. In spite of better antimicrobial agents and preventive measures, infections continue to be one of the most frequent complications in immunocompromised patients and have a high mortality rate of 30 to 90 % [2], with the highest when acute respiratory failure (ARF) occurs. Thus, early diagnosis and proper intervention are essential for better outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…The number of immunocompromised patients has increased dramatically over recent decades [2]. In spite of better antimicrobial agents and preventive measures, infections continue to be one of the most frequent complications in immunocompromised patients and have a high mortality rate of 30 to 90 % [2], with the highest when acute respiratory failure (ARF) occurs. Thus, early diagnosis and proper intervention are essential for better outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, biologic markers of CMV pp65 or CMV DNA by polymerase chain reaction are detectable at very early stages of infection. 70,71 To combat the effects of CMV infection, aggressive antiviral prophylaxis with valganciclovir or ganciclovir for up to 3 months following liver transplant is often employed. This approach, however, may result in delayed onset CMV disease once antivirals are discontinued.…”
Section: Ascariasismentioning
confidence: 99%
“…Furthermore, although the number of hospitalized patients with AIDS has declined, there is a growing number of other types of patients with compromised immune systems who require critical care services, many of them for complex infectious problems that involve unusual pathogens [16]. This "new age" immunocompromised population includes recipients of highrisk allogeneic hematopoietic stem cell and organ transplantation, myeloablative and cytotoxic chemotherapy, monoclonal antibodies, and other cellular and biological immunomodulating therapies.…”
Section: Synergy Of Ccm-id In the Clinical And Research Arenasmentioning
confidence: 99%